Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Board of Directors of Astra recommended that dividends be paid for 9 month 2024

11/20/24 ASTR

Renaissance Insurance's profit for 9 months of 2024 decreased by more than 50%

11/20/24 RENI

VK launches HeadHunter competitor for Job search

11/20/24 VKCO

MTS-Bank examines insurance assets for M&A

11/19/24 MBNK

Rostelecom to seriously reduce capex in 2025

11/19/24 RTKM

MTS ' net profit for the first 9 months of 2023 increased by 26%

11/19/24 MTSS

Astra's net profit for the first 9 months of 2024 increased by more than 50%

11/19/24 ASTR

MTSBANK's net profit for the first 9 months of 2024 increased by 8.2%.

11/19/24 MBNK

Board of Directors of MD Medical Group Investments recommended that dividends be paid for 9 month 2024

11/19/24 MDMG

Europlan's net profit for the first 9 months of 2024 increased by 6%

11/19/24 LEAS